Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

As the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...

It took another year for the FDA to grant interchangeability status to Rezvoglar, meaning it can be substituted at the ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...

Today, Plantsulin blends this century-old discovery with modern scientific validation to offer a fast, convenient “whole-body reboot” for maintaining optimal glucose levels. Unlike restrictive diets ...

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.